
    
      The inclusion will take place at the earliest at 20 weeks after the completion of the
      standard morphological ultrasound of the 2nd trimester (carried out at 20-24SA) and at the
      latest at 35 SA, within the framework of one of the 2 clinical subgroups of patients
      considered (high risk and low risk).

      The objectives of this study will be achieved by the prospective setting up of a LUMIERE
      cohort on PLACENTA.
    
  